Petersohn Walter 4

Accession 0001127602-21-029702

CIK 0000818479other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:28 PM ET

Size

29.2 KB

Accession

0001127602-21-029702

Insider Transaction Report

Form 4

Period: 2021-11-17

DENTSPLY SIRONA Inc.XRAY

Petersohn Walter

Chief Commercial Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−9,300→ 0 total
Exercise: $40.12Exp: 2028-08-09→ Common Stock (9,300 underlying)
Sale
Common Stock
2021-11-17$54.11/sh−17,748$960,291→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.09/sh−9,300$502,991→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.12/sh−9,134$494,359→ 25,740.103 total
Sale
Common Stock
2021-11-17$54.30/sh−34,068$1,849,790→ 36,487.103 total
Sale
Common Stock
2021-11-17$54.08/sh−10,747$581,232→ 25,740.103 total
Exercise/Conversion
Common Stock
2021-11-17$40.12/sh+9,300$373,116→ 35,040.103 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−17,748→ 0 total
Exercise: $47.41Exp: 2024-11-25→ Common Stock (17,748 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−5,434→ 10,866 total
Exercise: $47.84Exp: 2030-03-04→ Common Stock (5,434 underlying)
Exercise/Conversion
Common Stock
2021-11-17$47.41/sh+17,748$841,433→ 43,488.103 total
Exercise/Conversion
Common Stock
2021-11-17$49.29/sh+9,134$450,215→ 34,874.103 total
Exercise/Conversion
Common Stock
2021-11-17$47.84/sh+5,434$259,963→ 31,174.103 total
Sale
Common Stock
2021-11-17$54.09/sh−5,434$293,947→ 25,740.103 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-11-17−9,134→ 4,566 total
Exercise: $49.29Exp: 2029-03-12→ Common Stock (9,134 underlying)

Footnotes (10)

[F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F10]Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F7]This option is fully vested and exercisable.
[F8]This option is fully vested and exercisable.
[F9]Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

DENTSPLY SIRONA Inc.

CIK 0000818479

→

Entity typeother

Related Parties

filerCIK 0001501954

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 4:28 PM ET
Size: 29.2 KB

View on SEC.gov